Hematologic Malignancies
Showing NaN - NaN of 9
Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)
Terminated
- Hematologic Malignancies
- Itacitinib
- Calcineurin inhibitor
-
Aurora, Colorado
- +16 more
Apr 29, 2022
Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)
Terminated
- Hematologic Malignancies
- ProHema-CB
- Untreated CB
-
Duarte, California
- +10 more
Nov 26, 2021
Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference
Terminated
- Hematologic Malignancies
- Hypoproliferative Thrombocytopenia
- Mirasol platelets (MIR PLTs)
- Reference platelets (REF PLTs)
-
Washington, District of Columbia
- +9 more
Jul 28, 2021
Hematologic Malignancies Trial in Atlanta (Granulocyte Colony Stimulating Factor)
Terminated
- Hematologic Malignancies
- Granulocyte Colony Stimulating Factor
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Aug 10, 2017
Hematologic Diseases, Hematologic Malignancies Trial in Atlanta (Granulocyte Colony Stimulating Factor)
Completed
- Hematologic Diseases
- Hematologic Malignancies
- Granulocyte Colony Stimulating Factor
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Aug 19, 2014
Cord Blood Stem Cell Transplantation, Hematologic Malignancies Trial in United States (Cord blood transplantation)
Completed
- Cord Blood Stem Cell Transplantation
- Hematologic Malignancies
- Cord blood transplantation
-
Duarte, California
- +9 more
Mar 7, 2014
Hematologic Malignancies Trial in Atlanta (Busulfan, Cyclophosphamide and Fludarabine)
Completed
- Hematologic Malignancies
- Busulfan, Cyclophosphamide and Fludarabine
-
Atlanta, GeorgiaEmory Universtiy Winship Cancer Institute
Apr 5, 2012